| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.34M | 45.31M | 36.81M | 32.33M | 29.36M | 23.35M |
| Gross Profit | 25.10M | 45.31M | 36.81M | 32.33M | 29.36M | 23.35M |
| EBITDA | 23.64M | 22.85M | 18.47M | 17.78M | 12.54M | 8.23M |
| Net Income | 17.00M | 16.14M | 12.99M | 9.24M | 6.11M | 8.36M |
Balance Sheet | ||||||
| Total Assets | 66.89M | 62.44M | 52.46M | 51.95M | 41.35M | 31.55M |
| Cash, Cash Equivalents and Short-Term Investments | 35.30M | 33.25M | 24.94M | 26.62M | 21.86M | 17.10M |
| Total Debt | 1.21M | 848.00K | 659.00K | 268.00K | 539.00K | 743.00K |
| Total Liabilities | 10.97M | 11.89M | 9.13M | 10.16M | 10.30M | 7.10M |
| Stockholders Equity | 55.96M | 50.59M | 43.28M | 41.78M | 31.04M | 24.45M |
Cash Flow | ||||||
| Free Cash Flow | 18.88M | 18.25M | 13.66M | 12.91M | 13.35M | 8.47M |
| Operating Cash Flow | 19.05M | 18.75M | 14.02M | 13.23M | 13.64M | 8.82M |
| Investing Cash Flow | -1.22M | -1.00M | -1.55M | -470.00K | -3.11M | -509.00K |
| Financing Cash Flow | -10.69M | -10.47M | -14.12M | -7.98M | -5.75M | -4.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £594.02M | 5.68 | 30.00% | 8.73% | 7.71% | -7.39% | |
74 Outperform | £350.65M | 12.13 | 31.92% | 3.21% | 20.46% | 9.72% | |
74 Outperform | £851.25M | 8.25 | 7.11% | 2.70% | -4.38% | ― | |
72 Outperform | £210.75M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
70 Outperform | £2.09B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | £152.32M | 11.47 | 9.72% | 21.31% | -15.65% | -12.27% |